Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation
- 1 November 2006
- Vol. 24 (47-48), 6893-6904
- https://doi.org/10.1016/j.vaccine.2006.06.009
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine VectorsJournal of Virology, 2004
- Vaccines and Vaccine Strategies Against HIVCurrent Drug Targets, 2004
- Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA VaccinesJournal of Virology, 2003
- HIV vaccines 1983–2003Nature Medicine, 2003
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- The Development of Multi-epitope Vaccines: Epitope Identification, Vaccine Design and Clinical EvaluationBiologicals, 2001
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA VaccinationScience, 2000
- Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + LymphocytesScience, 1999
- Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1997